- Home
- FTLF vs DTIL Comparison
FTLF vs DTIL Comparison
Compare FTLF & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTLF | DTIL |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.1M | 194.3M |
| IPO Year | 2006 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FTLF | DTIL |
|---|---|---|
| Price | $9.31 | $6.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $21.50 | ★ $45.00 |
| AVG Volume (30 Days) | 37.0K | ★ 203.4K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.63 | N/A |
| Revenue | $21,744,000.00 | ★ $1,070,000,000.00 |
| Revenue This Year | $45.76 | N/A |
| Revenue Next Year | $5.10 | N/A |
| P/E Ratio | $14.91 | ★ N/A |
| Revenue Growth | ★ 11.52 | N/A |
| 52 Week Low | $8.67 | $3.53 |
| 52 Week High | $20.98 | $8.82 |
Technical Indicators
Market Signals| Indicator | FTLF | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 31.17 | 51.11 |
| Support Level | $8.67 | $4.56 |
| Resistance Level | $15.34 | $7.59 |
| Average True Range (ATR) | 0.57 | 0.46 |
| MACD | 0.15 | -0.11 |
| Stochastic Oscillator | 45.45 | 22.39 |
Price Performance
Historical ComparisonAbout FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).